| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.3M | -71.8% |
| Cost of Revenue | $1.2M | -77.9% |
| Gross Profit | $155K | +125.6% |
| R&D Expense | $184K | +2578.8% |
| Operating Income | -$3.5M | +44.6% |
| Pre-tax Income | -$6.2M | +16.1% |
| Net Income | -$6.2M | +15.9% |
| EPS (Basic) | $0.00 | — |
| EPS (Diluted) | $0.00 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $80K | -52.6% |
| Inventory | $11K | -99.0% |
| Current Assets | $953K | -65.7% |
| Total Assets | $1.8M | -53.7% |
| Current Liabilities | $33.2M | +11.4% |
| Total Liabilities | $33.3M | +9.8% |
| Stockholders' Equity | -$30.7M | -19.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.9M | -131.5% |
| Capital Expenditures | $11K | +414.1% |
| Investing Cash Flow | -$11K | -414.1% |
| Financing Cash Flow | $1.2M | +38.0% |
| Free Cash Flow | -$1.9M | -132.2% |
| — |